Back to search

Netherlands· NL-de2b5e9630da

Ampres 10 mg/ml oplossing voor injectie

A chloroprocaine product containing chloorprocaine hydrochloride, registered in Netherlands by Nordic Group B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC N01BA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAmpres 10 mg/ml oplossing voor inject…ATCN01BA04REGISTER NO.NL-de2b5e9630daPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Chloroprocaine is registered in 12 of 19 countries.

Countries holding a registration under ATC N01BA04 (chloroprocaine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Chloroprocaine · ATC N01BA04

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CHLOORPROCAINE HYDROCHLORIDE
Manufacturer
Nordic Group B.V.
Country
Netherlands (NL)
ATC code
N01BA04
ATC class
Chloroprocaine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    123670

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for chloroprocaine.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chloroprocaine · interactions on record

24 records

  • 23 moderate
  • 1 minor

Most severe, free to view

  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • SulfasalazineA07EC01moderate
  • LidocaineC05AD01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd42f42e-57ef-48d5-ae67-cf5ca38a18ae
GET /v1/drugs/cd42f42e-57ef-48d5-ae67-cf5ca38a18ae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intrathecaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123670_smpc.pdf",
  "strength": null,
  "atc_label": "Chloroprocaine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123670",
  "excipients": [
    "NATRIUMCHLORIDE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CHLOORPROCAINE HYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123670.pdf",
  "authorised_at": "2020/05/07",
  "procedure_number": "DE/H/5743/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123670",
  "additional_monitoring": "N"
}

See everything about chloroprocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.